Alpha Teknova (TKNO) Liabilities and Shareholders Equity (2020 - 2026)
Alpha Teknova (TKNO) reported Liabilities and Shareholders Equity of $98.7 million for Q1 2026, down 13.45% year-over-year from $114.0 million in Q1 2025, and down 4.76% quarter-over-quarter from $103.6 million in Q4 2025.
Alpha Teknova (TKNO) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $98.7 million in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $98.7 million, down 13.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $420.4 million (down 10.98% YoY), and the FY2025 annual result was $103.6 million, down 12.79% from the prior year.
- Liabilities and Shareholders Equity retreated to $98.7 million in Q1 2026 per TKNO's latest filing, from $103.6 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $184.1 million in Q1 2022 and troughed at $98.7 million in Q1 2026.
- A 5-year average of $131.3 million and a median of $124.1 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity gained 5.58% in 2022, then fell 27.25% in 2023.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $152.3 million in 2022, then fell by 15.55% to $128.6 million in 2023, then dropped by 7.64% to $118.8 million in 2024, then slipped by 12.79% to $103.6 million in 2025, then fell by 4.76% to $98.7 million in 2026.
- Business Quant data shows TKNO's Liabilities and Shareholders Equity at $98.7 million in Q1 2026, $103.6 million in Q4 2025, and $107.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 555.95 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 4.91 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.35 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 2.27 Bn |
| 10 | Alpha Teknova | 249.27 Mn | 231.49 Mn | 3.78 Mn | 98.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.66 Mn |
| Dec 31, 2025 | 103.58 Mn |
| Sep 30, 2025 | 107.63 Mn |
| Jun 30, 2025 | 110.49 Mn |
| Mar 31, 2025 | 113.99 Mn |
| Dec 31, 2024 | 118.77 Mn |
| Sep 30, 2024 | 124.10 Mn |
| Jun 30, 2024 | 115.35 Mn |
| Mar 31, 2024 | 120.82 Mn |
| Dec 31, 2023 | 128.59 Mn |
| Sep 30, 2023 | 138.39 Mn |
| Jun 30, 2023 | 132.55 Mn |
| Mar 31, 2023 | 141.02 Mn |
| Dec 31, 2022 | 152.26 Mn |
| Sep 30, 2022 | 160.27 Mn |
| Jun 30, 2022 | 182.20 Mn |
| Mar 31, 2022 | 184.08 Mn |
| Dec 31, 2021 | 166.51 Mn |
| Sep 30, 2021 | 169.16 Mn |
| Jun 30, 2021 | 172.57 Mn |